Illumina launches StrataMap Spatial solution
It provides whole-transcriptome spatial profiling with single-cell resolution and a large capture area, detecting 2x more genes per sample than probe-based methods.
See the latest news and media coverage for Illumina. We track all announcements, press releases, and industry mentions in real time, all in one place.
Genomic sequencing and array technology company
illumina.comLast updated
It provides whole-transcriptome spatial profiling with single-cell resolution and a large capture area, detecting 2x more genes per sample than probe-based methods.
The distributed kit enables clinical research labs to detect MRD via whole-genome sequencing with sensitivity as low as 10 ppm.
The former Labcorp CEO brings healthcare and diagnostics expertise to the board as Illumina accelerates its clinical strategy.
It details progress in equitable genomics access, sustainability, and community engagement.
New insider activity at Illumina ( ($ILMN) ) has taken place on June 1, 2026. Illumina insiders have recently executed notable stock sales involving two...
Private funds advised by Corvex sold 669,596 Illumina shares between May 28 and June 1 at about $147.50–$165.50 and terminated equity swaps on 24,562 shares.
A DNA sequencing startup will have to rejigger its antitrust lawsuit against Illumina after a California federal judge said it hasn't shown that the industry...
/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the StrataMap Spatial Solution, offering an unmatched breadth of coverage and...
Track Illumina and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.